Instil Bio (TIL) News Today $22.12 -1.89 (-7.87%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$22.18 +0.06 (+0.27%) As of 02/21/2025 06:39 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period Private equity firms who hold 38% of Instil Bio, Inc. (NASDAQ:TIL) gained 34%, institutions profited as wellFebruary 20 at 9:07 AM | finance.yahoo.comJMP Securities Keeps Their Hold Rating on Instil Bio (TIL)February 13, 2025 | markets.businessinsider.comSummit Therapeutics (NASDAQ:SMMT) Stock Quotes, Forecast and News SummaryJanuary 24, 2025 | benzinga.comInstil Bio Announces Clinical Progress in China for IMM2510/SYN-2510, a Clinical-Stage PD-L1xVEGF Bispecific AntibodyJanuary 14, 2025 | globenewswire.comInstil Bio upgraded to Buy from Hold at JefferiesJanuary 7, 2025 | markets.businessinsider.comJefferies Upgrades Instil Bio (TIL)January 7, 2025 | msn.comInstil Bio Stock Soars After Jefferies Upgrade On 'Early Mover' Cancer Drug Candidate: Retail JubilantJanuary 7, 2025 | msn.comInstil Bio Secures Loan to Refinance FacilityDecember 23, 2024 | tipranks.comCautious Hold Rating for Zura Bio Amid Efficacy Concerns and Licensing ChallengesNovember 18, 2024 | markets.businessinsider.comStrategic Acquisitions and Market Potential Position Instil Bio’s SYN-2510 as a Buy with High Growth ProspectsNovember 18, 2024 | markets.businessinsider.comInstil Bio price target lowered to $110 from $120 at H.C. WainwrightNovember 15, 2024 | markets.businessinsider.comInstil Bio Poised for Growth Amid Biopharmaceutical Sector Activity and Strong Financial PositionNovember 15, 2024 | markets.businessinsider.comMerck to buy rights to Chinese cancer drug for up to $3.3BNovember 14, 2024 | msn.comInstil Bio (TIL) Gets a Hold from JMP SecuritiesNovember 14, 2024 | markets.businessinsider.comInstil Bio initiated with a Market Perform at JMP SecuritiesNovember 5, 2024 | markets.businessinsider.comJMP Securities Initiates Coverage of Instil Bio (TIL) with Market Perform RecommendationNovember 5, 2024 | msn.comInstil Bio Positioned for Growth in Expanding PD-1xVEGF Market: Analyst Jack Allen Issues Buy RatingOctober 30, 2024 | markets.businessinsider.comAnalysis of Curative Ventures V LLC's Strategic Reduction in Instil Bio IncOctober 23, 2024 | finance.yahoo.comMainland China’s pharmaceutical sales to hit $345b by 2033October 10, 2024 | msn.comBay Area surfer, Scientologist and billionaire is tackling one of medicine's toughest problemsSeptember 30, 2024 | msn.comPerceptive Advisors LLC Acquires New Stake in Instil Bio IncSeptember 28, 2024 | finance.yahoo.com2 Stocks Up Over 700% in 2024 That Could Soar Even FurtherSeptember 25, 2024 | fool.comESMO 2024 Roundup: A Lot Of Stumbles, But There Are New Signs Of LifeSeptember 18, 2024 | seekingalpha.comInstil Bio’s SYN-2510: A Promising Oncology Candidate with Significant Revenue Potential and Competitive AdvantagesSeptember 17, 2024 | markets.businessinsider.comInstil Bio and ImmuneOnco Announce Global Registrational Strategy for PD-L1xVEGF Bispecific Antibody, SYN-2510/IMM2510, in Non-Small Cell Lung Cancer and Triple-Negative Breast CancerSeptember 16, 2024 | globenewswire.comUp More Than 500% in 2024. Can Instil Bio Keep Rocketing Higher?September 14, 2024 | fool.comInstil Bio: PD-L1/VEGF Bispecific Targeting With Unique EnhancementsSeptember 13, 2024 | seekingalpha.comInstil Bio Surges After Another Price-Target BoostSeptember 12, 2024 | marketwatch.comPrivate equity firms are Instil Bio, Inc.'s (NASDAQ:TIL) biggest owners and were rewarded after market cap rose by US$52m last weekSeptember 10, 2024 | finance.yahoo.comInstil Bio: A Buy Rating on Market Position and Strategic Partnerships in the PD-1/L1xVEGF SpaceSeptember 9, 2024 | markets.businessinsider.comInstil Bio Shares Rise After Exiting Operations in Manchester, U.K.September 9, 2024 | marketwatch.comInstil Bio Exiting Manchester, UK, Operations and Eliminating WorkforceSeptember 7, 2024 | marketwatch.comInstil Bio Inc (TIL)August 18, 2024 | investing.comInstil Bio’s Strategic Licensing and Financial Stability Underpin Buy RatingAugust 16, 2024 | markets.businessinsider.comInstil Bio Reports Second Quarter 2024 Financial Results and Provides Corporate UpdateAugust 13, 2024 | globenewswire.comInstil Bio’s Strategic Expansion and Pipeline Potential Bolster Buy RatingAugust 6, 2024 | markets.businessinsider.comWeek In Review: ImmuneOnco Out-Licenses 2 Antibodies In $2 Billion DealAugust 4, 2024 | seekingalpha.comInstil Bio to in-license cancer candidates from ImmuneOncoAugust 1, 2024 | msn.comInstil Bio Share Price (TIL.US)August 1, 2024 | lse.co.ukInstil Bio and ImmuneOnco Announce License and Collaboration Agreement for Development of IMM2510, a Potentially Best-in-Class PD-L1xVEGF Bispecific Antibody, and IMM27M, a Novel Next-Generation Anti-CTLA-4 AntibodyAugust 1, 2024 | globenewswire.comPremier Health Reports 2024 Second Quarter ResultsMay 23, 2024 | markets.businessinsider.comTIL Stock Earnings: Instil Bio Misses EPS for Q1 2024May 10, 2024 | investorplace.comInstil Bio, Inc. Q1 Loss DecreasesMay 10, 2024 | markets.businessinsider.comInstil Bio Reports First Quarter 2024 Financial Results and Provides Corporate UpdateMay 10, 2024 | finance.yahoo.comInstil Bio Reports First Quarter 2024 Financial Results and Provides Corporate UpdateMay 10, 2024 | globenewswire.comBiO-LiFE Herbalmeds Launches The Power of Sleep Campaign To Encourage Malaysians To Sleep Well and Stay HealthyMay 1, 2024 | finance.yahoo.comThis actor once saw father saved murder accused, qualified for Olympics, then became Bollywood's top villain, died at...April 21, 2024 | msn.comInstil Bio (TIL) Price Target Decreased by 23.15% to 28.22April 17, 2024 | msn.comJefferies cuts Instil Bio to hold, cites drug discontinuationApril 12, 2024 | msn.comInstil Bio Non-GAAP EPS of -$1.26 beats by $2.14March 22, 2024 | seekingalpha.com Get Instil Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for TIL and its competitors with MarketBeat's FREE daily newsletter. Email Address TIL Media Mentions By Week TIL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TIL News Sentiment▼1.200.60▲Average Medical News Sentiment TIL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TIL Articles This Week▼11▲TIL Articles Average Week Get Instil Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for TIL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ORIC News Today RAPP News Today SEPN News Today PGEN News Today STOK News Today CGEM News Today AUTL News Today VALN News Today XERS News Today TECX News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TIL) was last updated on 2/22/2025 by MarketBeat.com Staff From Our Partners[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIEDRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Instil Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Instil Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
